Member Info for YoungHarry

The fed's high interest rates in the 70s managed inflation and supressed POG but with US debt at $39 trillion and a fiscally incontinent government that option is not open to Kevin Warsh

Stefan is plain speaking tells it without fanfare, it almost had to be dragged out of him when he confirmed the Export and Investment Fund of Demark is interested in financing the construction stage which is when the European Investment Bank will come in. He's planning for the mine and processing plant to be operational from late 29, now ''known in the industry as a future supplier of natural graphite anode material''

investors are being warmed up for another dilutive placing, be interesting to see if the investor is the contract miner.
One way or another TK will happen, it's too important to the EG not to but the market is valuing KEFI on its negative view of Harry. That's the investment opportunity.

Takes us back to old days, after GGP announced HAD 005, the share price fell, after GGP announced the first JV with Newcrest, the share price fell. Latest results not as significant as the above but warrant they are exceptional.

Tomorrow marks 9 weeks since drill commencement, looking back on GGP announcements would expect results after 10 weeks but that was from a single site campaign. Reasonable to expect some drills with copper and gold, just a question of grades, depth, strike.

Seven full trading days to Harry's brr media interview, booked for 2.00pm Monday 26th October

The FDA is one of the US's institutional advantages, however abuse of such advantages would ultimately lead to their loss. So we can be confident the FDA will assess the submission on its merits. It may be approved as submitted, if further data is required required then it would be for sound reasons and with a view to enable the FDA to approve. Once approved a US structural advantage kicks in, big bio med is US owned, one of these corporates will take out AGL and reinforce its global competitiveness. It is then just a matter of time for FDA approval and corporate action (which may proceed the putative NASDAQ listing). The corporate action may be in the form of licence deal or take out. Either way the share price will be at a premium.

Hi Paddy
It's quite something to be quoted by a commodities fund manager at an international conference
Noted, Wilhelm went so far as to suggest a discovery of 15m oz.

www.brrmedia.co.uk

Rincon the only unquoted company with tenements in the Paterson, including 50,000 ha 12km south of Telfer. The company is lining up a drill campaign...quoted Gunsynd with a miniscule market cap has a 28% stake, just saying...

Harry has booked an interview on BRR media 2.00pm Monday 26th October, presumably he's hopeful he will be able to chat about a recently issued RNS....

Drilling commenced 19th August, nearly five weeks in, expect first assays any time after 21st October

An excellent post, generally Harry's achievements are not widely recognised on this BB. I wonder how many keyboard warriors have run a quoted explorer in two tricky jurisdictions and found gold and copper?
Looks as if the high gold price and regime imperatives in Ethiopia (mine as largest generator of foreign earnings) and Saudi (mining as part of diversifying an oil dependent economy) will see all projects over the line. Along way further drilling to increase the resources should value the inevitable placings.

There are several drivers for the share price. We know from HAV they will have made a visual inspection of the first drill at Scally. Remember HAD001 was great, the technology derived data is showing them to drill. Then we have a new broker target of 17.8p and what appears to be a shed load of drill data in Newcrest's hands pending the MRE later this year. After the Christmas break, what's to stop Newcrest from making a bid?

From GGP's first drill campaign commencing 18th April 2018 to the farm in deal in March 2019, the share price hardly reflected the significance of the drill results and deal with Newcrest. This time, similar news will not go unnoticed.
Ten weeks after 18th April 2018, GGP announced 'exceptional laboratory assay results from HAD001. Just two weeks later, GGP announced results for HAD 002, 003, 004 with 'potential to host a large mineralised system.'
Two weeks after the second campaign started, GGP issued an update announcing 'significant visual mineralisation' at HAD005 (end of hole 822m). One poster reported on this board it was very pretty (or words to that effect). Seven weeks later we had results from HAD005 (world class) and three weeks after that observations from 006,007,008 and 009. The results followed on 5th February 2019, a few weeks before the farm in deal.
So two conclusions a) news from the latest campaign could start to drop from mid October and b) this time round phrases such as 'potential to host a large mineralised system' can be taken seriously. Any one for a shallow copper / gold system at Scallywag?

The evidence is pointing to a gold / copper field or district but we need to wait for results from GGP's drilling campaign

The first narrative was along the lines we were about to submit by 31st March but we were a few blood tests short. It follows Agl would be a few days / weeks from submission once the blood tests could be resumed. Not in Agl world. Turns out there was a lot of documentation to work on and now there is another step (5min 9 seconds into the video) some key submissions need to be reviewed by the leading cancer centre in the US before submission to the FDA. Apparently they are under pressure...there could be second wave (and we all know Donald has a tight grip on Covid)...AN sticking with submission in Q3. Investors could draft the nearly there but not quite RNS in their sleep...

Massively undervalued

No BoD is going to flag a cash call, the market would simply drop the share price. Given the Lanstead deal, IMM is concerned to keep the sp up. The reality is that cash continues to be spent (it takes £500k pa to keep the wolf from the Zimmer family door) and to add to the pressure a further £250k is committed to Incanthera in October 2020. In the absence of a deal with up front cash, its just a matter of time before a cash call.

IMM bought 363,637 shares at £5.50, it appears there has been a 1 for 20 split which prices the new shares at 25.25p. IMM's holding rises to 7,272,740 shares and remains circa 14% + of the pre money 51,810,000 shares.
Given the post money dilution to 11.97%, this suggests post money 60,798,900 shares and valuation of £15.35m.
At 25.25p, this would raise £2.27m before expenses. Of this sum Tim has committed to pay circa £900k for 3,566,474 shares.
Positive news for IMM as Incanthera will soon have the cash needed to commercialise their lead product over the next 18 months

(IMM have bought 363,637 shares at £5.50 it appears those shares have split tobeen divivesh ave sose os it appears ahres .